National Center for Advancing Translational Sciences; Notice of Closed Meeting, 9164 [2024-02651]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
9164
Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices
Service Act (42 U.S.C. 300aa–1), the
Secretary of HHS was mandated to
establish the National Vaccine Program
to achieve optimal prevention of human
infectious diseases through
immunization and to achieve optimal
prevention against adverse reactions to
vaccines. The NVAC was established to
provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
During this meeting, NVAC will hear
presentations to support the recent
charge on innovation from Admiral
Rachel L. Levine, MD, the Assistant
Secretary for Health and Director of the
National Vaccine Program. NVAC will
also hear presentations on recent surges
in measles cases, the Vaccines for
Children’s Program, real uses of
artificial intelligence to support
vaccination efforts, and supply chains.
Presenters will also cover ways to
improve immunization of children,
adults, and pregnant people. Please note
that agenda items are subject to change,
as priorities dictate. Information on the
final meeting agenda will be posted
prior to the meeting on the NVAC
website: https://www.hhs.gov/nvpo/
nvac/.
Members of the public will have the
opportunity to provide comment at the
NVAC meeting during the public
comment period designated on the
agenda. Public comments made during
the meeting will be limited to three
minutes per person to ensure time is
allotted for all those wishing to speak.
Members of the public may also submit
written comments. Written comments
should not exceed three pages in length.
Individuals planning to submit
comments should email their written
comments or their request to provide a
comment during the meeting to nvac@
hhs.gov at least five business days prior
to the meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 11, 2024.
Ann Aikin,
Acting Designated Federal Official, Office of
the Assistant Secretary for Health.
BILLING CODE 4140–01–P
[FR Doc. 2024–02636 Filed 2–8–24; 8:45 am]
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Study Section Digestive Diseases
and Nutrition C Study Section.
Date: March 13–15, 2024.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NIDDK
Democracy II, Suite 7000A, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7009,
Bethesda, MD 20892, (301) 594–4721,
kozelp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02697 Filed 2–8–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4150–44–P
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:20 Feb 08, 2024
Jkt 262001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Understudied Proteins
Associated with Rare Diseases (R03) Review.
Date: May 30, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892.
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Center for Advancing Translational
Sciences, National Institutes of Health, 6701
Democracy Boulevard, MSC 4874, Bethesda,
MD 20892, (301) 827–4312, ming.yan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: February 5, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02651 Filed 2–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Mental Health Special Emphasis Panel
BRAIN K99, March 6, 2024, 11:00 a.m.
to March 06, 2024, 6:30 p.m., National
Institutes of Health, Neuroscience
Center, 6001 Executive Boulevard,
Rockville, MD 20852 which was
published in the Federal Register on
February 2, 2024, FR Doc. 2024–02045,
89 FR 7403.
The meeting date has changed from
March 6, 2024, to March 15, 2024. The
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 89, Number 28 (Friday, February 9, 2024)]
[Notices]
[Page 9164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Understudied Proteins Associated
with Rare Diseases (R03) Review.
Date: May 30, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Boulevard, Bethesda,
MD 20892.
Contact Person: Ming Yan, MD, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
National Center for Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy Boulevard, MSC 4874, Bethesda,
MD 20892, (301) 827-4312, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: February 5, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02651 Filed 2-8-24; 8:45 am]
BILLING CODE 4140-01-P
